Tang Fei, Du Shuguo, Zhao Yun, Sun Guoqiang, Lin Ying, Li Ruyan, Wu Xufeng
Department of Obstetrics, Maternal and Child Health Hospital of Hubei Province, Affiliated Hospital of Tongji Medical College, Huazhong University of Science and Technology.
Department of Gynecology and Oncology, Maternal and Child Health Hospital of Hubei Province, Affiliated Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Medicine (Baltimore). 2019 Jan;98(4):e14266. doi: 10.1097/MD.0000000000014266.
It is very difficult to treat patients with placenta previa who underwent pregnancy termination and suffered antenatal massive hemorrhage in the 2nd trimester.
In this study, case 1 was with fetal malformation of 18-trisomy syndrome at gestation of 19 weeks + 2 days, case 2 was with fetal malformation of 18-trisomy syndrome at gestation of 22 weeks + 1 day, and case 3 was for intrauterine fetal death at gestation of 27 weeks. All the 3 cases were completely placenta previa.
For the 3 patients, completely placenta previa was confirmed by ultrasound examination after hospitalization and underwent pregnancy termination for fetal death or fetal malformation in the 2nd trimester.
The 3 patients with placenta previa underwent pregnancy termination by mifepristone combined with ethacridine lactate in the 2nd trimester for intrauterine fetal death or fetal malformation from June 2017 to May 2018, and suffered antenatal massive hemorrhage during termination. Uterine artery embolization (UAE) was immediately performed to achieve hemostasis, then double balloon catheter (DBC) was carried out to promote cervical ripen, at last curettage was implemented with the help of ultrasound. After all these procedures, the clinical outcomes were observed.
The antenatal bleeding volume of these 3 patients were about 500, 600, and 550 mL. After implementing the combined treatment, all patients completed the abortion. The UAE-DBC time interval and DBC-curettage time interval were 58.4 and 6.0 hours, respectively, for case 1, whereas almost 0 (i.e., immediately) for cases 2 and 3. Case 1 had a fever lasting for 3 days, and the maximum body temperature was up to 39°C after UAE. Moreover, the blood culture was positive for Escherichia coli after curettage in case 1, whereas it was negative in the other 2 cases.
The UAE-DBC-curettage combined treatment is safe and effective for patients with placenta previa who undergo pregnancy termination and suffered massive antenatal hemorrhage in the 2nd trimester. Future studies are needed to advance our observation.
对于妊娠中期终止妊娠且发生产前大出血的前置胎盘患者,治疗非常困难。
本研究中,病例1在妊娠19周+2天时胎儿为18-三体综合征畸形,病例2在妊娠22周+1天时胎儿为18-三体综合征畸形,病例3在妊娠27周时胎儿宫内死亡。所有3例均为完全性前置胎盘。
3例患者入院后经超声检查确诊为完全性前置胎盘,因胎儿死亡或畸形于妊娠中期终止妊娠。
2017年6月至2018年5月,3例前置胎盘患者因胎儿宫内死亡或畸形于妊娠中期采用米非司酮联合乳酸依沙吖啶终止妊娠,终止妊娠期间发生产前大出血。立即行子宫动脉栓塞术(UAE)止血,然后置入双球囊导管(DBC)促进宫颈成熟,最后在超声引导下刮宫。完成所有这些操作后,观察临床结局。
这3例患者产前出血量分别约为500、600和550 mL。实施联合治疗后,所有患者均完成流产。病例1的UAE-DBC时间间隔和DBC-刮宫时间间隔分别为58.4小时和6.0小时,而病例2和病例3几乎为0(即立即进行)。病例1发热持续3天,UAE后最高体温达39°C。此外,病例1刮宫后血培养大肠杆菌阳性,其他2例为阴性。
UAE-DBC-刮宫联合治疗对于妊娠中期终止妊娠且发生产前大出血的前置胎盘患者安全有效。需要进一步研究以推进我们的观察。